West Pharmaceutical Services - 15 Year Stock Price History | WST

Historical daily share price chart and data for West Pharmaceutical Services since 2011 adjusted for splits and dividends. The latest closing stock price for West Pharmaceutical Services as of June 11, 2026 is 330.34.
  • The all-time high West Pharmaceutical Services stock closing price was 465.69 on December 30, 2021.
  • The West Pharmaceutical Services 52-week high stock price is 336.82, which is 2% above the current share price.
  • The West Pharmaceutical Services 52-week low stock price is 206.80, which is 37.4% below the current share price.
  • The average West Pharmaceutical Services stock price for the last 52 weeks is 262.20.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
West Pharmaceutical Services Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2026 270.7599 275.9390 334.6600 230.7760 330.3400 20.26%
2025 250.5979 326.7790 346.1630 189.5760 274.6810 -15.73%
2024 333.5523 346.1540 410.2180 275.4400 325.9530 -6.75%
2023 344.8403 232.1620 409.1640 230.2700 349.5590 49.97%
2022 310.8056 440.5780 440.5780 207.1580 233.0930 -49.70%
2021 363.5888 281.5860 465.6940 253.8440 463.3910 65.88%
2020 221.2271 149.1550 297.2800 126.8920 279.3570 89.05%
2019 124.2455 94.2882 148.6340 92.4496 147.7690 54.13%
2018 99.1304 96.7535 121.0920 81.1362 95.8726 -0.08%
2017 88.3422 81.2598 98.8442 76.0973 95.9464 17.02%
2016 70.2484 55.2791 82.4487 52.5494 81.9944 41.87%
2015 54.4640 49.6553 61.5460 46.9295 57.7935 14.03%
2014 43.2321 45.9169 52.4351 37.2822 50.6834 9.53%
2013 34.7944 25.7567 47.2374 25.5561 46.2753 81.24%
2012 21.9832 17.5051 25.9898 17.3399 25.5328 46.63%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $18.493B $3.074B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $106.025B 23.03
Cardinal Health (CAH) United States $50.715B 22.43
Becton Dickinson (BDX) United States $43.913B 11.10
Straumann Holding AG (SAUHY) Switzerland $16.902B 0.00
Cooper (COO) United States $13.894B 16.52
Align Technology (ALGN) United States $12.400B 21.09
Henry Schein (HSIC) United States $8.645B 15.16
Merit Medical Systems (MMSI) United States $4.072B 19.84
DENTSPLY SIRONA (XRAY) United States $2.339B 7.36
STAAR Surgical (STAA) United States $1.309B 0.00
CONMED (CNMD) United States $1.107B 7.97
Pro-Dex (PDEX) United States $0.165B 19.65
Lifevantage (LFVN) United States $0.053B 5.46
Axe Compute (AGPU) United States $0.022B 0.00